HCC Specialty Series – Michael Morse, MD
This live activity is focused on treatment strategies for patients with hepatocellular carcinoma (HCC).
This live activity is focused on treatment strategies for patients with hepatocellular carcinoma (HCC).
This live activity will cover treating and managing patients with sleep-related disorders.
This activity will cover the treatment and management of patients with AML and CLL.
This live activity is focused on treatment strategies for patients with hepatocellular carcinoma (HCC).
This activity will cover the treatment and management of patients with non-metastatic castration-resistant prostate cancer (nmCRPC).
This live activity is focused on treatment strategies for patients with hepatocellular carcinoma (HCC).
This live activity is focused on treatment strategies for patients with hepatocellular carcinoma (HCC).
This case-based live activity will cover the treatment and management of patients with hemophilia A
This live activity is focused on treatment strategies for patients with hepatocellular carcinoma (HCC).
This activity will cover the treatment and management of patients with AML and CLL.
This program will review the use of CDK 4/6 inhibitors in the treatment of HR+/HER2-negative breast cancer and the management of treatment-related adverse events.
This live activity is focused on treatment strategies for patients with hepatocellular carcinoma (HCC).